Dirk von Lewinski

Medical University of Graz

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (7)

Harald Sourij

AUSTRIA

View details

Markus Wallner

Medical University of Graz

AUSTRIA

View details

Philippe Meyer

University Hospital of Geneva

SWITZERLAND

View details

Jonas Sundermeyer

University Heart and Vascular Center Hamburg

GERMANY

View details

Florian A. Wenzl

University of Zurich

SWITZERLAND

View details

David Kajetan Zach

Medical University of Graz

AUSTRIA

View details

Mark Petrie

University of Glasgow

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dirk von Lewinski

Research Interests

Explore related searches

Contact this professor

Articles (11)

Timing of veno‐arterial extracorporeal membrane oxygenation support in patients with cardiogenic shock

Ambient Temperature and the Frequency of Subsequent Heart Failure Decompensations in an Emergency Department

Temporal Trends in Takotsubo Syndrome

Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry.

Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Air Pollution and Myocardial Infarction—A New Smoker’s Paradox?

Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.

Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.

Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program.

SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction

Collaborators (7)

Harald Sourij

Markus Wallner

Philippe Meyer

Jonas Sundermeyer

Florian A. Wenzl

David Kajetan Zach

Mark Petrie

Make your next move.